Metformin displayed a lowest risk for dementia across diverse antidiabetics, while α-glucosidase inhibitors had the highest risk.
Suicidal ideation, behaviors not increased with GLP-1 RAs for seniors with T2D
Jul 16, 2024
No significant increase was seen with the use of GLP-1 RAs versus SGLT2is or DPP4is among older Medicare beneficiaries.
Mean cost of bringing new drug to US market Is $879.3 million
Jul 02, 2024
R&D has remained relatively stable among large pharma companies despite a 27.3% growth in sales.
New COVID-19 drug guards against all variants in immunocompromised
Apr 28, 2023
The trial results could be out by September and may lead to the FDA emergency use authorization.
Managing medications: Tips for seamless caregiving
By
Kara James, PhD
Jan 19, 2023
With staffing challenges not improving soon and a growing senior population, finding solutions for medication management in senior living communities and nursing homes could help save lives.
AI may be useful in polypharmacy management
Apr 24, 2024
ChatGPT deprescribing decisions varied along activities of daily living status, cardiovascular disease history, and medication type